Tonix Pharmaceuticals Holding Corp at ThinkEquity Conference Transcript
My name is Nick Christian. I'm with ThinkEquity. Our next presenting company is Tonix Pharmaceuticals, so I'll turn it over to them.
Hi. Thank you very much. Thank you to ThinkEquity for having Tonix at this conference, and welcome to everyone in person and also attending via webcast. I am Jessica Morris, the Chief Operating Officer with Tonix Pharmaceuticals.
Tonix is a publicly traded company. We're traded on NASDAQ under the ticker TNXP. So here is our standard Safe Harbor statement. I will be making forward-looking statements, and I refer you to our SEC filings for complete information.
So Tonix is a clinical-stage biopharmaceutical company. And ultimately our mission, our vision is to invent and develop new innovative therapies as well as new vaccines for people in need around the world. And how do we propose to do that? This is covered in our investment highlights. So I'll start at the top.
We have a diverse and robust pipeline
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
